International Alliance of Patient Organisations
The Guardian reports:
- IAPO was set up in 1999 by 38 patient groups with funds from the Pharmaceutical Partners for Better Healthcare, a collaboration of some 40 drug companies. Pharmaceutical Partners closed down that same year, throwing IAPO into serious financial difficulties. Pfizer stepped in with a grant in 2002 to help IAPO develop a strategy for the future. A variety of individual companies have supported it since then. In 2006, drug companies contributed $250,554 (£127,000) out of a total income of $278,755. In 2006, GSK, Pfizer, Medtronic and Novartis were the biggest sponsors, each providing more than $50,000 a year.
- Sarah Boseley, health editor Drug firms and patient groups join in fight to overturn advertising ban Monday May 21, 2007 The Guardian